 patents Novartis India drugs generic HIV drug industry Trips Glivec Europe multinational erosion profits copycat manufacturers pirates European governments profitable pharmacy World Trade Organisation Swiss innovation stakes evergreening Médecins Sans Frontières Africa tuberculosis hepatitis C Trans-Pacific Partnership Australia Canada Malaysia Chile Mexico Peru Vietnam incentives boycott monopoly